Cellular & Gene Therapies
Viral Vector Therapeutics, Gene Therapy
Angionetics Inc., is a company focused on the late-stage clinical development and commercialization of Generx®, an angiogenic gene therapy product candidate designed for medical revascularization ...
custom-made recombinant viral vectors
AAV Gene Therapy Treatments
Gene silencing technology
Adeno-Associated Virus Delivery, Gene Therapy
Gene therapies for rare and orphan neurological genetic diseases
BEAT Biotherapeutics Corp. (BEATBio) is developing BB-R12, a novel gene therapy with the potential to revolutionize the treatment of heart failure.
Develops next-generation product candidates in some of the most important areas of cellular immunotherapy, including hematopoietic stem cell transplantation (HSCT), CAR T cell therapy, and TCR ...
A biopharmaceutical company. They discover, develop, and deliver medicines to treat serious disease.
Genetically targeted medicine
Gene Therapy, Orphan Diseases
Gene Transfer Technology
Gene Therapy platform technology
Gene Therapy for Cancer
Engineers B cells through gene therapy to produce proteins that combat disease.
Gene Therapy or 'genomic medicine'
Gene therapy cancer treatment
Gene shuffling technology
Site-Specific Gene Modification System
Plasmid and Adenovirus Purification
Gene Therapy, Biologics
We are Sarepta Therapeutics: a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics. Our goal is to harness the power of cutting-edge technology
to improve ...
Singe Dose Gene Therapy
Uses recombinant Adeno-associated virus to engineer and edit genomes and make universal donor cells.